Home › Funds › Evolutionary Tree Capital Management, LLC › ASND

Evolutionary Tree Capital Management, LLC position in ASND

ASCENDIS PHARMA A/S · Health Care

Evolutionary Tree Capital Management, LLC reported holding 6,038 shares of ASND (ASCENDIS PHARMA A/S) in its Q3 2026 13F filing — a position valued at US$1.4M, representing 2.55% of its reported portfolio and ranking #17 among its reported holdings. Evolutionary Tree Capital Management, LLC has disclosed ASND holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)6.04K sh
Reported value held$1.38M
Portfolio Weight2.55%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Evolutionary Tree Capital Management, LLC's ASND position evolved

Evolutionary Tree Capital Management, LLC first disclosed a stake in ASND in Q3 2023 at 16,657 shares (US$1.6M). The position peaked in Q3 2024 at 32,753 shares, worth US$4.9M. Across 13 filings, Evolutionary Tree Capital Management, LLC increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 6,038 shares valued at US$1.4M. Notable position changes include a 82% increase in Q2 2024 (shares rose 9% over the following quarter), a 32% increase in Q3 2024 (shares fell 8% over the following quarter), a 33% trim in Q2 2026 (shares fell 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 16.66K $1.56M New
Q4 2023 16.73K $2.11M Hold
Q1 2024 13.64K $2.06M Reduce
Q2 2024 24.86K $3.39M Add
Q3 2024 32.75K $4.89M Add
Q4 2024 30.11K $4.15M Reduce
Q1 2025 20.66K $3.22M Reduce
Q2 2025 18.45K $3.19M Reduce
Q3 2025 15.34K $3.05M Reduce
Q4 2025 12.28K $2.62M Reduce
Q1 2026 9.07K $2.07M Reduce
Q2 2026 6.05K $1.61M Reduce
Q3 2026 6.04K $1.38M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ASND and 13F data

ASND (ASCENDIS PHARMA A/S) is a Health Care company. 37 other funds we track also report a position in ASND — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$2.74B), T. Rowe Price Investment Management, Inc. (US$1.80B), Avoro Capital Advisors LLC (US$1.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ASND

All ASND fund holders →

FAQ

How long has Evolutionary Tree Capital Management, LLC held ASND?

Evolutionary Tree Capital Management, LLC has disclosed ASND holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Evolutionary Tree Capital Management, LLC's current position in ASND?

As of Q3 2026, Evolutionary Tree Capital Management, LLC holds 6.04K shares of ASND (ASCENDIS PHARMA A/S), valued at $1.38M, representing 2.55% of its reported portfolio and ranking #17.

Has Evolutionary Tree Capital Management, LLC been buying or selling ASND?

In the latest 13F filing (Q3 2026), Evolutionary Tree Capital Management, LLC held unchanged its position in ASND. The position peaked in Q3 2024 at 32.75K shares.

Which other funds hold ASND?

Other major institutional holders of ASND include RA CAPITAL MANAGEMENT, L.P., T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.